PMHSOTCPharmaceutical PreparationsFiscal year ends December 31
Polomar Health Services, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.12−0.01 (-4.00%)
Close on Oct 19, 2026
- Market cap
- $3.37M
- P/E (TTM)
- –
- Dividend yield
- –
Polomar Health Services, Inc. revenue by segment
By business segment
By product or service
| Revenue | Q2 26 | Q2 25 | % of revenue | YoY |
|---|---|---|---|---|
| Prescription Fulfillment [Member] | $1.53M | – | 100.0% | – |
| Others [Member] | – | $5.47K | – | – |
By region
From the segment and revenue-disaggregation notes of Polomar Health Services's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.